By Dr Melvin Teck Meng Chin

Journal articles

Taggart J; Chin M; Liauw W; Harris MF, 2024, 'Sharing Colorectal Cancer Follow-Up Using an E-Care Plan Between Cancer Services and Primary Health Care', Studies in Health Technology and Informatics, 310, pp. 1517 - 1518, http://dx.doi.org/10.3233/SHTI231272

Newman B; Chin M; Robinson L; Chauhan A; Manias E; Wilson C; Harrison R, 2023, 'Improving Medication Safety in Cancer Services for Ethnic Minority Consumers: Protocol for a Pilot Feasibility and Acceptability Study of a Co-Designed Consumer Engagement Intervention', JMIR Research Protocols, 12, pp. e49902, http://dx.doi.org/10.2196/49902

Chauhan A; Newman B; Roberto E; Walpola RL; Seale H; Chin M; Harrison R, 2023, 'Making it Meaningful : Co-designing an intervention to improve medication safety for people from culturally and linguistically diverse backgrounds accessing cancer services', Patient Experience Journal, 10, pp. 34 - 48, http://dx.doi.org/10.35680/2372-0247.1732

Pitiyarachchi O; Wong W; Chin M, 2022, 'Durvalumab and multimodality therapy in a patient with multiple recurrent and unresectable cutaneous squamous cell carcinoma', Internal Medicine Journal, 52, pp. 1103 - 1104, http://dx.doi.org/10.1111/imj.15809

Harrison R; Chin M; Ni She E, 2022, 'What does co-design mean for Australia's diverse clinical workforce?', Australian Health Review, 46, pp. 60 - 61, http://dx.doi.org/10.1071/AH21116

Harrison R; Walton M; Manias E; Wilson C; Girgis A; Chin M; Leone D; Seale H; Smith AB; Chauhan A; Smith B; Walpola R, 2021, 'Codesigning consumer engagement strategies with ethnic minority consumers in Australian cancer services: The CanEngage Project protocol', BMJ Open, 11, pp. e048389, http://dx.doi.org/10.1136/bmjopen-2020-048389

Taggart J; Chin M; Liauw W; Goldstein D; Dolezal A; Plahn J; Harris MF, 2021, 'Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice', Public Health Research and Practice, 31, http://dx.doi.org/10.17061/PHRP31122108

McLean LS; Faisal W; Parakh S; Kao SC; Lewis CR; Chin MT; Voskoboynik M; Itchins MJ; Jennens RR; Broad AR; Morris TA; Solomon BJ, 2021, 'Standard-dose osimertinib in egfr-mutated non-small-cell lung adenocarcinoma with leptomeningeal disease', JCO Precision Oncology, 5, pp. 561 - 568, http://dx.doi.org/10.1200/PO.20.00464

Vuong K; Uebel K; Agaliotis M; Jun S; Taggart J; Suchy S; Liauw W; Chin M; Webber K; Harris M, 2020, 'Assessing suitability for long-term colorectal cancer shared care: a scenario-based qualitative study', BMC Family Practice, 21, pp. 240, http://dx.doi.org/10.1186/s12875-020-01311-w

Ali A; Dumbrava M; Riddell K; Stewart N; Ward R; Ibrahim AK; Chin M, 2020, 'Correlation between initial tumour volume and treatment duration on Dabrafenib: Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial', BMC Cancer, 20, pp. 342, http://dx.doi.org/10.1186/s12885-020-06848-8

Taggart J; Chin M; Liauw W; Dolezal A; Plahn J; Harris MF, 2019, 'Development of an interactive, web-based shared care plan to facilitate the follow-up care of colorectal cancer patients', , http://dx.doi.org/10.21203/rs.2.13454/v2

Lamprell K; Chin M; Braithwaite J, 2019, '“Can I still get a tattoo?” Patients’ experiences across the clinical trajectory for metastatic melanoma: a dynamic narrative model of patient journey', Patient Experience Journal, 6, pp. 87 - 93, http://dx.doi.org/10.35680/2372-0247.1301

Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Butler J; Rawson R; Phan-Thien KC; Thompson SR; Braithwaite J; Chin M; Taylor N, 2018, 'Using behaviour change and implementation science to address low referral rates in oncology', BMC Health Services Research, 18, pp. 904, http://dx.doi.org/10.1186/s12913-018-3653-1

Lamprell K; Chin M; Braithwaite J, 2018, 'The plot thickens: Archetypal narrative structure in the melanoma patient journey', Cogent Medicine, 5, pp. 1484053, http://dx.doi.org/10.1080/2331205x.2018.1484053

Liang R; Meiser B; Smith S; Kasparian NA; Lewis CR; Chin M; Long GV; Ward R; Menzies AM; Harris-Wai JN; Kaur R, 2017, 'Advanced cancer patients’ attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study', European Journal of Cancer Care, 26, http://dx.doi.org/10.1111/ecc.12600

Schütze H; Chin M; Weller D; Harris MF, 2017, 'Patient, general practitioner and oncologist views regarding long-term cancer shared care.', Fam Pract, 35, pp. 323 - 329, http://dx.doi.org/10.1093/fampra/cmx105

Pianta TJ; Pickering JW; Succar L; Chin M; Davidson T; Buckley NA; Mohamed F; Endre ZH; Abdul Cader MF, 2017, 'Dexamethasone Modifies Cystatin C-Based Diagnosis of Acute Kidney Injury During Cisplatin-Based Chemotherapy', Kidney and Blood Pressure Research, 42, pp. 62 - 75, http://dx.doi.org/10.1159/000469715

Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; segelov E; Boyle FM; Chin MT; webber K; Barry BK; Lloyd AR, 2017, 'Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue.', Journal of Pain and Symptom Management, http://dx.doi.org/10.1016/j.jpainsymman.2017.03.015

Lemech CR; Williams R; Thompson SR; McCaughan B; Chin M, 2016, 'Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: A case report', BMC Research Notes, 9, pp. 386, http://dx.doi.org/10.1186/s13104-016-2189-x

Bloem LT; De Abreu Lourenço R; Chin M; Ly B; Haas M, 2016, 'Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer', Oncology and Therapy, 4, pp. 103 - 116, http://dx.doi.org/10.1007/s40487-016-0020-4

He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study', ONCOLOGIST, 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530

He EYJ; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: An Australian population-based multicenter study', Oncologist, 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530

Taylor N; Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Braithwaite J; Chin M, 2016, 'Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: A study protocol', BMC Health Services Research, 16, pp. 89, http://dx.doi.org/10.1186/s12913-016-1331-8

Au L; Grant M; Haydon A; Oliva K; Wilkins S; Segelov E; Antill Y; Peter C; Ranchod P; Polglase A; Chin M; Chip F; Skinner S; Roger W; McMurrick P; Shapiro J, 2016, '198P Use of chemotherapy and mismatch repair deficiency testing in resected stage II colon cancer', Annals of Oncology, 27, http://dx.doi.org/10.1093/annonc/mdw581.031

Sandler C; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; Segelov E; Boyle FM; Chin MTM; Barry BK; Webber K; Lloyd AR, 2015, 'TOPS: A randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue.', Journal of Clinical Oncology, 33, pp. 9571 - 9571, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.9571

Falchook GS; Long GV; Kurzrock R; Kim KB; Arkenau HT; Brown MP; Hamid O; Infante JR; Millward M; Pavlick A; Chin MT; O'Day SJ; Blackman SC; Martin C; Lebowitz P; Ma B; Ouellet D; Kefford RF, 2014, 'Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)', Clinical Cancer Research, 20, pp. 4449 - 4458, http://dx.doi.org/10.1158/1078-0432.CCR-14-0887

Mak G; Chin M; Nahar N; De Souza P, 2014, 'Cutaneous metastasis of prostate carcinoma treated with radiotherapy: A case presentation', BMC Research Notes, 7, pp. 505, http://dx.doi.org/10.1186/1756-0500-7-505

Mak G; Arkenau HT; Chin M, 2014, 'Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment', Melanoma Research, 24, pp. 408 - 412, http://dx.doi.org/10.1097/CMR.0000000000000085

Chin M; Ward RL, 2014, 'Targeting treatment for colorectal cancer: The EGFR antibody story', Cancer Forum, 38, pp. 39 - 43

Pianta T; Chin M; Peake P; Buckley N; Pickering J; Endre Z, 2013, 'PLASMA CYSTATIN C IS ELEVATED IN THE ABSENCE OF ACUTE KIDNEY INJURY FOLLOWING CISPLATIN WITH CONTEMPORARY ANTIEMETICS', NEPHROLOGY, 18, pp. 41 - 41, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323453000103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mak G; Ward R; Shehabi Y; Venkateswaran R; Chin M, 2013, 'Use of neostigmine in capecitabine-induced paralytic ileus', Tumori, 99, http://dx.doi.org/10.1177/030089161309900518

Mak G; Ward R; Shehabi Y; Venkateswaran R; Chin M, 2013, 'Use of neostigmine in capecitabine-induced paralytic ileus', Tumori Journal, 99, pp. e225 - e228, http://dx.doi.org/10.1177/030089161309900518

Lemech CR; Fontela A; Arkenau H-T; Chin MTM; Li S; Liauw WS; Thomas D; De Souza PL, 2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours.', Journal of Clinical Oncology, 30, pp. e13585 - e13585, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e13585

Pourgholami MH; Szwajcer M; Chin M; Liauw W; Seef J; Galettis P; Morris DL; Links M, 2010, 'Phase i clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605, http://dx.doi.org/10.1007/s00280-009-1157-8

Pourgholami MH; Szwajcer ; Chin MTM; Liauw WS; Szwajcer ; Galettis P; Morris DL; Links MJ, 2010, 'Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605, http://dx.doi.org/10.107/s00280-009-1157-8

Pearson S; Chin M; Faedo M; Ward RL, 2010, 'Rationale for treatment durations of targeted cancer agents', Lancet Oncology, 11, pp. 1113 - 1115, http://dx.doi.org/10.1016/S1470-2045(10

Grimison PS; T Chin M; Harrison ML; Goldstein D; Chin M, 2006, 'Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, 6, pp. 117, http://dx.doi.org/10.1186/1471-2407-6-117

Wierzbicki AS; Reynolds TM; Crook MA; Tatler J; Peters BS; McBride M; Chin MTM; Lee SM; Kelly B, 1998, 'Lipid lowering therapy in patients with HIV infection (multiple letters) [3]', Lancet, 352, pp. 1782 - 1783, http://dx.doi.org/10.1016/s0140-6736(05)79858-5

Conference Papers

Chin TTC; Botes LLB; Chin MMC, 2017, 'Compassionate Supply of Oncology Drugs Within the South Eastern Sydney Local Health District (SESLHD) in 2011-2015', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 188 - 188, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500311&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Segelov E, 2015, 'TOPS - a randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, presented at 2015 ASCO Annual Meeting, Chicago, 29 May 2015 - 02 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036902066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D; Liauw W; Boyle F; Goldstein D; Lloyd A, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lemech C; Fontela A; Arkenau H; Chin M; Li S; Liauw WS; Thomas D; De Souza P, 2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours', in Journal of clinical oncology - official journal of the American Society of Clinical Oncology, American Society of Clinical Oncology, New York, pp. e13585 - e13585, presented at ASCO Annual Meeting, Chicago, USA, 01 June 2012 - 05 June 2012, http://meeting.ascopubs.org/gca?gca=ascomtg%3B30%2F15_suppl%2Fe13585&allch=&submit=Go#abstr-1

Herder GJ; Agulnik J; Amadori D; Chin M; Chouaid C; Ek L; Lester J; Ziske C; Eriksson J; Finnern H; Vansteenkiste J, 2011, 'Describing treatment, treatment outcomes, resource use and quality of life of advanced NSCLC patients – the Lung Cancer Economics and Outcomes Research (LUCEOR) studies.', in Journal of Thoracic Oncology, Lippincott Williams & Wilkins, USA, pp. 1404 - 1405, presented at Proceedings of the 14th World Conference on Lung Cancer, Amsterdam, http://dx.doi.org/10.1097/01.JTO.0000399290.73317.eb

Pearson S; Chin M; Ward RL, 2009, 'The Financially Tolerable Dose: A New Concept in Cancer Trial Design', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S173 - S174, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269009900396&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Conference Posters

Taggart J; Spooner C; Simpson A; Jun S; Chin M; Liauw W; Harris MF, 2023, 'Sharing care between specialist health services and primary health care using interactive e-care plans', Online, presented at Digital Health Forum, Online, 07 February 2023

Chin M, 2021, 'Telemedicine in the context of Covid-19: A qualitativestudy of cancer patients and clinicians', presented at Clinical Oncology Society Australia Annual Scientific Meeting, 16 November 2021

Bailey S; Ehrlich R; Lapin D; Chin M, 2020, 'Clinical audit of chest drain complications in medical oncology patients', Virtual, Vol. 16, pp. 142 - 143, presented at Clinical Oncology Society Australia Annual Scientific Meeting 2020, Virtual, 11 November 2020 - 13 November 2020, http://dx.doi.org/10.1111/ajco.13498

Abdelmogod A; Robinson L; Coleman L; Chah K; Chin M; O'Neill S, 2020, 'Retrospective analysis of chemotherapy‐induced febrile neutropenia; Local experience towards risk‐based management', Virtual, Vol. 16, pp. 142 - 142, presented at Clinical Oncology Society Australia Annual Scientific Meeting, Virtual, 11 November 2020 - 13 November 2020, http://dx.doi.org/10.1111/ajco.13498

Williams R; Long J; Debono D; Chin MT; Taylor N, 2017, 'WORKING WITH CLINICIANS TO IDENTIFY BARRIERS TO FAMILY CANCER CLINIC REFERRALS FOR PATIENTS AT HIGH RISK OF LYNCH SYNDROME', Florence, presented at InSIGHT 7th Biennial Meeting, Florence, 05 July 2017 - 08 July 2017, http://www.2017insight.com/

Feeney K; Chin M; Ng S; Matos M; Mak G; McKendrick J, 2014, 'AFLIBERCEPT IN METASTATIC COLORECTAL CANCER (MCRC): DATA FROM CLINICAL TRIALS, LESSONS FROM CLINICAL PRACTICE', Melbourne, Vol. 10 Supplement S8, pp. 192 - 192, presented at COSA, Melbourne, 21 October 2014 - 24 October 2014, http://dx.doi.org/10.1111/ajco.12305

Back to profile page